Association between CD103 and E-cadherin Immunoexpression with Pelvic Lymph Node Metastasis in Cervical Squamous Cell Carcinoma

Author:

Yantisetiasti Anglita1,Rej Henny Sri1,Suryanti Sri1,Dewayani Birgitta Maria1,Winarno Gatot Nyarumenteng Adhipurnawan1,Kireina Jessica1,Chandra Anita Riau1,Mantilidewi Kemala Isnainiasih1,Hernowo Bethy Suryawathy1,Susiarno Hadi1

Affiliation:

1. Padjadjaran University

Abstract

Abstract

Background Lymph node (LN) metastasis is a poor prognostic factor for cervical squamous cell carcinoma (SCC). One important predictor of LN metastasis is lymphocytic inflammatory reaction, which may be indicated by infiltration of CD103 + CD8 + T cells. CD103 will bind to its ligand, E-cadherin which causes enhancement of CD8 + T cells cytotoxic function against tumor cells. This study aims to examine the relationship between CD103 and E-cadherin immunoexpression with pelvic LN metastases in cervical SCC. Methods A formalin-fixed paraffin-embedded (FFPE) cervical SCC of the patients who underwent hysterectomy and lymphadenectomy between 2013 and 2018 at Dr. Hasan Sadikin General Hospital, Bandung were analyzed. Twenty FFPE with LN metastasis were analyzed and equal number of control were compared. All samples were immunostained with CD103 and E-cadherin and immunoexpression was analyzed by Kolmogorov Smirnov and Chi-square. The p-value of 0.05 was considered significant. Results This study showed a significant association between CD103 immunoexpression and pelvic LN metastases (p < 0.01). There was no significant relationship between E-cadherin immunoexpression and pelvic LN metastases (p > 0.05). Conclusion Our study revealed that CD103 immunoexpression in cervical SCC is associated with pelvic LN metastases in cervical SCC by a mechanism that may not require E-cadherin expression.

Publisher

Research Square Platform LLC

Reference33 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021

2. GIlks B. Female Reproductive System. In: Goldblum J, Lamps L, McKenney J, Myers J, editors. Rosai and Ackerman’s Surgical Pathology. Elsevier; 2018. pp. 1288–90.

3. Hacker N, Jackson M, Vermoken J. Cervical Cancer. In: Berek JS, Hacker NF, editors. Berek & Hacker’s Gynecologic Oncology. 7th ed. Wolters Kluwer; 2021.

4. Ellenson LH, Carinelli S, Kim KR, Kupryjanczyk J, Part J, Singer G, et al. WHO Classification of Tumours of Female Reproductive Organs. In: Kurman RJ, Carcangiu M, Young RH, editors. WHO Classification of Tumours of Female Reproductive organs. IARC; 2014. p. 41.

5. Wahidin M, Febrianti R, Susanty F. Burden of Cervical Cancer in Indonesia: Findings From the Global Burden of Disease Study 1990–2017. In: Proceedings of the 4th International Symposium on Health Research (ISHR 2019) [Internet]. Bali, Indonesia: Atlantis Press; 2020 [cited 2024 May 7]. https://www.atlantis-press.com/article/125935010.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3